Close

TRIM24

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

TRIM24 mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. It localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. It is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains - a RING, a B-box type 1 and a B-box type 2 - and a coiled-coil region.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YJ357 Anti-TRIM24 (1A2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ358 Anti-TRIM24 (1D1) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1D1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ359 Anti-TRIM24 (1D4) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1D4 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ360 Anti-TRIM24 (1G5) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1G5 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ361 Anti-TRIM24 (2D9) h(41BB-CD3ζ) CAR, pCDCAR1 Human 2D9 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ362 Anti-TRIM24 (2F2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 2F2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ363 Anti-TRIM24 (2H1) h(41BB-CD3ζ) CAR, pCDCAR1 Human 2H1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ364 Anti-TRIM24 (3A8) h(41BB-CD3ζ) CAR, pCDCAR1 Human 3A8 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ857 Anti-TRIM24 (1A2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ858 Anti-TRIM24 (1D1) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1D1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ859 Anti-TRIM24 (1D4) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1D4 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ860 Anti-TRIM24 (1G5) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1G5 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ861 Anti-TRIM24 (2D9) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2D9 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ862 Anti-TRIM24 (2F2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2F2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ863 Anti-TRIM24 (2H1) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2H1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ864 Anti-TRIM24 (3A8) h(CD28-CD3ζ) CAR, pCDCAR1 Human 3A8 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.